Dose-Dependent Anti-Inflammatory and Neuroprotective Effects of anανβ3 Integrin-Binding Peptide

Shu Han,Jing Yang,Fan Zhang,Marong Fang,Henry Davies,Yayi Sun,David T W Yew,Zhiying Hu

doi:10.1155/2013/268486

Abstract

Previous studies have shown that prevention of leukocyte infiltration by targeting integrins involved in transendothelial migration may suppress the clinical and pathological features of neuroinflammatory disease. This study was designed to investigate the effects of C16, an α ν β3 integrin-binding peptide, in an acute experimental allergic encephalomyelitis (EAE) rat model. Multiple histological and immunohistochemical staining, electron microscopy observation, ELISA assay, Western blot, and magnetic resonance imaging (MRI) were employed to assess the degree of inflammation, axonal loss, neuronal apoptosis, white matter demyelination, and extent of gliosis in the brain and spinal cord of differently treated EAE models. The results showed that C16 treatment could inhibit extensive leukocyte and macrophage accumulation and infiltration and reduce cytokine tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) expression levels. A significantly lower clinical score at the peak time of disease was also demonstrated in the C16 treated group. Moreover, astrogliosis, demyelination, neuronal death, and axonal loss were all alleviated in C16 treated EAE animals, which may be attributed to the improvement of microenvironment. The data suggests that C16 peptide may act as a protective agent by attenuating inflammatory progression and thus affecting the expression of some proinflammatory cytokines during neuroinflammatory disease.

Highlights

Multiple Sclerosis (MS) is a progressive autoimmune disease that invokes an inflammatory attack on the central nervous system (CNS) resulting in an accumulating disability [1, 2]
EAE was induced in the rats for C16 treatment and the vehicle control groups by subcutaneously injection of 0.2 mL 1 : 1 mixture of guinea pig spinal cord homogenate (GPSCH) and complete Freud adjuvant (CFA), containing 0.5 mg of heat killed mycobacterium tuberculosis (Difco Laboratories, Detroit, MI)
At the peak time of the disease (2 weeks after immunization), Hematoxylin and eosin (H&E) staining of the cerebral cortex and spinal cord (Figure 1) revealed a significant increase of the cellular density in EAE rats treated with vehicle

Summary

Introduction

Multiple Sclerosis (MS) is a progressive autoimmune disease that invokes an inflammatory attack on the central nervous system (CNS) resulting in an accumulating disability [1, 2]. EAE includes the breakdown of the blood-brain barrier, infiltration of the CNS by CD4 T cells and macrophages, and activation of microglia and astrocytes. This results in inflammation followed by demyelination [1, 4, 5]. Activated microglia and astrocytes have been implicated in the secretion of a number of proinflammatory mediators, such as TNF-α, IFN-γ, and metalloproteinases, which act as inflammatory mediators and tissue damaging agents in the onset of EAE [1, 6, 7]. Secondary neuronal loss and astrogliosis underlie the deterioration of EAE [11, 12]

Methods

Results

Discussion

Conclusion